meningococcal disease caused by meningitis B

• Healthcare
• Pharma & Biotech
• Switzerland

Novartis: FDA granted accelerated approval of Bexsero® for active immunization to prevent invasive meningococcal disease caused by meningitis B

With today's approval, Bexsero is now licensed in 37 countries; since first approval in Europe, over 1 million doses have…